Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis

Area of Science:

• Immunology
• Neuroscience
• Cell Biology

Background:

• Dendritic cells (DCs) are key antigen-presenting cells regulating T cell responses in multiple sclerosis (MS).
• Interferon-beta (IFN-β) is a therapeutic agent for MS, but its precise effects on DC function remain incompletely understood.

Purpose of the Study:

• To investigate the role of IFN-β in regulating DC immunophenotype and function during experimental autoimmune encephalomyelitis (EAE), a mouse model of MS.
• To determine if IFN-β deficiency impacts DC activation, cytokine production, and migration.

Main Methods:

• Utilized a myelin oligodendrocyte glycoprotein (MOG) peptide-induced EAE mouse model.
• Compared DCs from wild-type (IFN-β^+/+) and knockout (IFN-β^-/-) mice.
• Analyzed DC immunophenotype, cytokine secretion, T cell proliferation, and migration following MOG peptide stimulation and EAE induction.

Main Results:

• IFN-β^-/- DCs exhibited enhanced CD80 and MHCII expression and secreted cytokines favoring T helper type 17 (Th17) polarization over regulatory T cells (Tregs).
• IFN-β^-/- DCs promoted greater proliferation and interleukin-17 (IL-17) production in MOG-specific CD4⁺ T cells.
• Adoptive transfer of IFN-β^-/- DCs led to their rapid migration into the central nervous system (CNS) prior to disease onset, linked to impaired STAT1-mediated CCR7 inhibition.

Conclusions:

• IFN-β plays a crucial immunoregulatory role in controlling DC activation and CNS migration during EAE.
• IFN-β deficiency promotes a pro-inflammatory DC phenotype, contributing to EAE pathogenesis.
• These findings highlight potential therapeutic targets within DC-mediated immune responses in MS.